• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

撤回通知：TNFAIP8通过抑制p53介导的miR-205-5p表达促进三阴性乳腺癌的顺铂化疗耐药性。

Retraction Notice to: TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression.

作者信息

Ma Hong-Yu, Li Yang, Yin Hui-Zi, Yin Hang, Qu Yuan-Yuan, Xu Qing-Yong

出版信息

Mol Ther Nucleic Acids. 2023 Oct 5;34:102048. doi: 10.1016/j.omtn.2023.102048. eCollection 2023 Dec 12.

DOI:10.1016/j.omtn.2023.102048
PMID:37829327
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10565844/
Abstract

[This retracts the article DOI: 10.1016/j.omtn.2020.09.025.].

摘要

[本文撤回文章DOI: 10.1016/j.omtn.2020.09.025。]

相似文献

1
Retraction Notice to: TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression.撤回通知：TNFAIP8通过抑制p53介导的miR-205-5p表达促进三阴性乳腺癌的顺铂化疗耐药性。
Mol Ther Nucleic Acids. 2023 Oct 5;34:102048. doi: 10.1016/j.omtn.2023.102048. eCollection 2023 Dec 12.
2
TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression.TNFAIP8通过抑制p53介导的miR-205-5p表达促进三阴性乳腺癌的顺铂化疗耐药性。
Mol Ther Nucleic Acids. 2020 Sep 26;22:640-656. doi: 10.1016/j.omtn.2020.09.025. eCollection 2020 Dec 4.
3
Retraction Notice to: circPHIP promotes oral squamous cell carcinoma progression by sponging miR-142-5p and regulating PHIP and ACTN4 expression.撤稿声明：环状PHIP通过吸附miR-142-5p并调节PHIP和ACTN4表达促进口腔鳞状细胞癌进展。
Mol Ther Nucleic Acids. 2021 Dec 4;26:1479. doi: 10.1016/j.omtn.2021.11.017. eCollection 2021 Dec 3.
4
Retraction Notice to: LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells.撤回通知：LINC01234/微小RNA-31-5p/MAGEA3轴介导肝癌细胞的增殖和化疗耐药性
Mol Ther Nucleic Acids. 2022 Dec 11;31:14. doi: 10.1016/j.omtn.2022.12.004. eCollection 2023 Mar 14.
5
TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.TNFAIP8 通过 MDM2/p53 通路促进非小细胞肺癌的增殖和顺铂化疗耐药性。
Cell Commun Signal. 2018 Jul 31;16(1):43. doi: 10.1186/s12964-018-0254-x.
6
Retraction Notice to: Circular RNA Cdr1as Upregulates SCAI to Suppress Cisplatin Resistance in Ovarian Cancer via miR-1270 Suppression.撤回通知：环状RNA Cdr1as通过抑制miR-1270上调SCAI以抑制卵巢癌顺铂耐药性
Mol Ther Nucleic Acids. 2024 May 19;35(2):102213. doi: 10.1016/j.omtn.2024.102213. eCollection 2024 Jun 11.
7
Retraction Notice to: circ_001653 Silencing Promotes the Proliferation and ECM Synthesis of NPCs in IDD by Downregulating miR-486-3p-Mediated CEMIP.撤稿声明：环状RNA circ_001653通过下调miR-486-3p介导的CEMIP沉默促进椎间盘退变中髓核细胞的增殖和细胞外基质合成
Mol Ther Nucleic Acids. 2023 Jan 27;31:352. doi: 10.1016/j.omtn.2023.01.012. eCollection 2023 Mar 14.
8
Retraction Notice to: A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID.撤回通知：一种由微小RNA-501-5p抑制的BLID介导的阿霉素耐药性和肿瘤发生的新机制
Mol Ther Nucleic Acids. 2022 Nov 9;30:378. doi: 10.1016/j.omtn.2022.11.002. eCollection 2022 Dec 13.
9
Retraction Notice to: lncRNA UCA1 Promotes Gefitinib Resistance as a ceRNA to Target FOSL2 by Sponging miR-143 in Non-small Cell Lung Cancer.撤回通知：lncRNA UCA1 通过在非小细胞肺癌中吸附 miR-143 作为竞争性内源 RNA 靶向 FOSL2 促进吉非替尼耐药性。
Mol Ther Nucleic Acids. 2024 May 18;35(2):102215. doi: 10.1016/j.omtn.2024.102215. eCollection 2024 Jun 11.
10
Retraction Notice to: circRASSF2 Acts as ceRNA and Promotes Papillary Thyroid Carcinoma Progression through miR-1178/TLR4 Signaling Pathway.撤稿通知：环状RASSF2作为竞争性内源RNA并通过miR-1178/TLR4信号通路促进甲状腺乳头状癌进展。
Mol Ther Nucleic Acids. 2021 Nov 17;26:1199. doi: 10.1016/j.omtn.2021.11.003. eCollection 2021 Dec 3.